Marketable Securities, Current in USD of Design Therapeutics, Inc. from Q4 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Design Therapeutics, Inc. quarterly Marketable Securities, Current history and growth rate from Q4 2020 to Q3 2025.
  • Design Therapeutics, Inc. Marketable Securities, Current for the quarter ending September 30, 2025 was $191M, a 14.7% decline year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)

Design Therapeutics, Inc. Quarterly Marketable Securities, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $191M -$32.9M -14.7% Sep 30, 2025 10-Q 2025-11-05
Q2 2025 $197M -$18.7M -8.71% Jun 30, 2025 10-Q 2025-08-07
Q1 2025 $216M -$25.3M -10.5% Mar 31, 2025 10-Q 2025-05-07
Q4 2024 $223M -$37.7M -14.5% Dec 31, 2024 10-Q 2025-11-05
Q3 2024 $224M -$39.3M -14.9% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $215M -$60.6M -22% Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $241M -$45.3M -15.8% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $261M -$43.3M -14.2% Dec 31, 2023 10-K 2025-03-10
Q3 2023 $263M -$38.7M -12.8% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $276M +$36.2M +15.1% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $287M +$203M +242% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $304M +$218M +255% Dec 31, 2022 10-K 2024-03-19
Q3 2022 $302M +$266M +737% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $240M +$208M +649% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $83.9M +$73.3M +688% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $85.5M +$51.8M +154% Dec 31, 2021 10-K 2023-03-14
Q3 2021 $36.1M Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $32M Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $10.6M Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $33.7M Dec 31, 2020 10-K 2022-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.